A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
Status:
Completed
Trial end date:
2018-12-27
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety, tolerability, and pharmacokinetics
of MT-2990 in patients with Japanese cedar pollen-induced seasonal allergic rhinitis
(JC-SAR). Additional objective of the study is to investigate the efficacy and
pharmacodynamics profile of MT-2990 in an environmental exposure chamber (EEC) on Day 8, 29,
57, and 85.